Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child
Publication date
2021-10-07
Authors
Blom, Maartje
Pico-Knijnenburg, Ingrid
van Montfrans, JM
Bredius, Robbert G.M.
van der Burg, Mirjam
Swen, Jesse J.
Berghuis, Dagmar
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Immunology and Allergy, Immunology
Citation
Blom, M, Pico-Knijnenburg, I, van Montfrans, J M, Bredius, R G M, van der Burg, M, Swen, J J & Berghuis, D 2021, 'Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero : Benefit of TPMT Genotyping in Both Mother and Child', Journal of Clinical Immunology, vol. 42, no. 1, pp. 199-202. https://doi.org/10.1007/s10875-021-01138-9